<DOC>
	<DOCNO>NCT00281567</DOCNO>
	<brief_summary>Comparison lung function response tiotropium inhalation solution Spiriva HandiHaler .</brief_summary>
	<brief_title>Efficacy Safety Comparison Tiotropium Inhalation Solution ( Respimat Inhaler ) Spiriva HandiHaler Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Diagnosis COPD FEV1 &lt; 60 % predict FEV1 &lt; 70 % FVC Smoking history 10 packyears Significant disease COPD Recent history MI ( 1 year less ) Cardiac arrhythmia require drug therapy History asthma , allergic rhinitis eosinophil count &gt; 600 mm3 Symptomatic prostatic hypertrophy bladder neck obstruction Known narrowangle glaucoma Abnormal baseline hematology , blood chemistry urinalysis History cancer within last 5 year Lifethreatening pulmonary obstruction Cystic fibrosis bronchiectasis Tuberculosis Pulmonary resection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>